Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia

Figure 1

The comparisons of serum Cys-C in various groups of patients with prostate neoplasia. The comparison of serum Cys-C in total patients with prostate neoplasia () (a); in patients with normal SCr () (b); in patients with high SCr () (c); in BPH patients () (d); in PCa patients () (e); in PIN patients () (f). : parametric Student’s -test.

(a)

(b)

(c)

(d)

(e)

(f)